quotable quotes - March 2012
"It would be very interesting to study dapagliflozin in people with type 1 diabetes. Particularly in young people, they emit glucose and end up way out of control and with complications. Maybe adding dapagliflozin to insulin could be a useful way to treat type 1 diabetes."
- Dr. John Wilding (University of Liverpool, Liverpool, United Kingdom) on using the SGLT-2 inhibitor dapagliflozin, a new diabetes drug in development, at Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Latin America; March 22-25, 2012; Rio de Janeiro, Brazil.
"Imagine bariatric surgery was a pill. You take it and get all the benefits. All obesity-related diseases disappear and you get a better personality. You will also look better. But there is a one out of 100 chance you will drop down and die. Would FDA approve it? ... This is not metformin. It’s a major decision for the patient. [But] it’s probably the most effective treatment for well informed and motivated patients.."
- Dr. Roy Eldor (University of Texas, Health Science Center, San Antonio, TX) at Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Latin America; March 22-25, 2012; Rio de Janeiro, Brazil.
"You will see more and more of this combination."
- Dr. Stefano Del Prato (University of Pisa, Italy) on the combination of insulin use and GLP-1 at Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Latin America; March 22-25, 2012; Rio de Janeiro, Brazil.
